Investment Q&A

Q: my ACB is $56. CXR is not a big part of my portfolio and in my TFSA. I was going to buy more on the low 30's then the Blackrock news came out. the price has now come back to $36/$37. My planned purchase would bring my ACB down to $46 at the current price. Am I throwing good money after bad? If CXR is sold now does it get more than $65/share? Or less because of the debt load? If you were a potential buyer what would you pay? What is your advice? Thanks

Q: Hello.
After all the conversation about CXR today, the rumour about Blackstone recently and some with clear support for CXR, how do we know that CXR did not just fabricate the rumour to boost stock price or go to Blackstone desperate for a deal before the company explodes?

Thanks for your thoughts.
Dave

Q: Do you think the short selling attack (justified or not) on CXR makes it a sell....even with a potential offer from Blackrock?

Q: Hi 5i Team,
Is it still okay to purchase CXR at today's closing price. I know the downside if the sale does not go through, but what is the upside if it does go through.
As always, thanks for your great service.
Ivan

Q: With CXR paying its dividend in US dollars, do you think a bid for the company would be in US or Canadian dollars? Thanks!
Linda

Q: Greetings, Peter and Co.
I currently have 14.8% of my investments, excluding real estate and bullion, in the biotech/healthcare sector. I hold
Biosyent (RX) 0.5% (I have a considerable loss in RX.)
Concordia (CXR) – 1.5% (I expect CXR to be acquired by a larger company.)
Merus Labs (MSL) – 2.2%
Prometic (PLI) – 2.4%
Amgen (AMGN) – 3.1%
Knight (GUD) – 5.1%
I am considering liquidating my holdings in CXR, RX and perhaps MSL and using the proceeds to add to my PLI position and/or an alternative that you might recommend unless you think I am too overweight in this sector.
Thank you for your analysis and recommendations.
With appreciation
Ed

Q: Looking to understand the process a bit better. At what point does a board of directors need to disclose that they have been approached about a possible sale? How do they decide whether to go public or to keep confidential? What are the odds a deal is announced this weekend?

Regards,

Robert

Q: I currently own CXR but underwater so would you still recommend this stock a buy with all news happening?

Dolores

Q: Why would Concordia agree to enter into discussions with Blackrock (or others) if they have confidence in their ability to integrate recent acquisitions, roll out newly-acquired drugs across a larger geographic area, and generally execute on their business plans? Doesn't it suggest management see insurmountable issues ahead in one or more areas? Thank you for your comments.

Q: Hi Peter and Team,
What is the reasonable take over price for Concordia?

Thanks

Q: What is the most likely scenario with Cxr tomorrow after it was halted today,do you think it will trading at the opening bell or what has to happen to "unhault " trading have 300 shares and have a nice profit on a quick trade just wandering the best way to sell tomorrow thanks for your great service

Q: Concordia has been acting very poorly for quite some time, especially since their last earnings report. Is it still being associated too much with VRX or is there something else? (i.e management compensation) I do not want to exit my position as this seems so cheap based on forward earnings. I know they have a ton of debt but this should be managed based on their forecasts. Is this just a case of the market being short sighted?

Q: I'm wondering why a trading halt would last for so long when the news is already out, and it's something as benign as preliminary discussions after being approached by another party. Is there something else coming?

Q: what do you make of the buyout news?

Q: This might be a tough question but I am pretty sure you would have seen it before. I need strategic help. I can’t seem to sell a losing stock. I am paralyzed by the fear that by selling I lock in the loss. Or that at the current price it is actually the time to buy the stock.
Surprisingly even with this list of losers my portfolio is actually up. Much to the credit of 5i. So I don’t need to sell but can’t help thinking that the money could be put to better use. I am also pretty sure that there could be different advice for each stock. But anyway here is my list. What do you think? Sell or hold?
Please take as many question points as you feel is appropriate.
TMA -21%
GH -20%
GS -30%
HLF -33%
PM -25%
WEF -20%
AYA – 45%
CXR -34%
PHM – 79%

Q: hi team, could you list me five growth stocks unfairly punished that are paying a dividend

Thanks Dave

Q: Hello Peter, Concordia appears to be breaking down here. It looks like a downward trajectory since sept. I would like to down average but it appears to be falling now daily. What should I do here wait or buy my full position.

Thanks
Kevin

Q: I currently own a small position in Concordia, approximately 2% weighting and I am considering buying more based on the CEO comments today reinforcing the auditors report. Please give me your views of the company presently and your longer term prognosis. I know how leveraged the company is but do you believe they are a "Valeant" in the making ?

Q: BNN reported that Pacific Square removed from their report what they said about PriceWaterHouse Cooper. Also, CEO of Concordia discredited the report. Apparently, the short report can't be found anymore. Seems that easy money is being made writing short reports. Can't blame investors for selling after PHM, VRX, AYA, GXI only in 12 months and so many "good" stocks taking the elevator down.

Q: In your Mar 23 response, you indicated guidance was key...so I scanned their 2015 AR looking for guidance. I expected to find some 2016 goals and a CEO signature. Only found the Executive Summary...where the only guidance is they "expect" to de-lever by paying down some debt...& unsigned. No commitment or targets there. Your thoughts?